Business Standard

Fed, Covid-19 drug hopes lift indices; monthly gains at 11-year high

Stocks opened gap-up after a sharp rally on the Wall Street overnight, and managed to hold on to most gains despite banking stocks, the index heavyweights, underperforming

Markets
Premium

The benchmark indices ended the truncated week with 7.7 per cent gain

Sundar Sethuraman Mumbai
The benchmark indices soared on Thursday, on hopes of a breakthrough in finding a possible drug for Covid-19 treatment, as well as the US Federal Reserve’s assurances to continue with stimulus measures to revive the economy.

Stocks opened gap-up after a sharp rally on the Wall Street overnight, and managed to hold on to most gains despite banking stocks, the index heavyweights, underperforming.

The Sensex closed at 33,718, up 997 points or 3.05 per cent, while the Nifty rallied 306 points or 3.2 per cent to end at 9,860. The Bank Nifty Index gained 2.1 per cent.

Most Asian indices logged gains but

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in